Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topicort Spray Add-on in Psoriasis Patients on Biologics
NCT02983981Phase 4Completed
- Sponsor
- Psoriasis Treatment Center of Central New Jersey
- Start
- Mar 2016
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, open-label, single-arm trial of desoximetasone in psoriasis, sponsored by Psoriasis Treatment Center of Central New Jersey. Primary endpoint: Psoriasis Severity at 16 weeks. Started Mar 2016; status: completed.
02
Drugs
desoximetasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02983981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02983981.